Skip to main content
. 2024 Apr 17;8(2):e194–e201. doi: 10.1055/s-0044-1785525

Fig. 4.

Fig. 4

Laboratory tests and precautions to be taken into account if emicizumab is used. FVIII, coagulation factor VIII; HA, hemophilia A; PTT, partial thromboplastin time.